This was highlighted in an experimental study performed on GLP-1-treated HL-1 cardiomyocytes, in which GLP‐1 increased calcium transients and sarcoplasmic reticular calcium contents by regulating the expression of calcium handling proteins, leading to a reduced calcium leak and thus preventing AF development [34]. This evidence concerns the gene GLP1R and atrial fibrillation.